Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®.
- DOI
- 10.1016/j.therap.2021.12.006
- Published
- 2022 Mar-Apr
- Container
- Therapie
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.therap.2021.12.006,
title = {Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®.},
author = {Strumia M and Perrin ML and Patras de Compaigno E and Conte C and Montastruc F and Lapeyre-Mestre M and Sibaud V and Despas F},
year = {2022},
journal = {Therapie},
doi = {10.1016/j.therap.2021.12.006},
url = {https://doi.org/10.1016/j.therap.2021.12.006}
}RIS
TY - JOUR TI - Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®. AU - Strumia M AU - Perrin ML AU - Patras de Compaigno E AU - Conte C AU - Montastruc F AU - Lapeyre-Mestre M AU - Sibaud V AU - Despas F PY - 2022 JO - Therapie DO - 10.1016/j.therap.2021.12.006 UR - https://doi.org/10.1016/j.therap.2021.12.006 ER -
APA
M, S., ML, P., E, P. D. C., C, C., F, M., M, L., V, S., & F, D. (2022). Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®.. Therapie. https://doi.org/10.1016/j.therap.2021.12.006
Source records
- pubmed · retrieved 2026-09-25T13:54:11.392Z